Skip to content

Clinical trials

Completed Cardiomyopathy, Hypertrophic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Hypertrophic Status: Completed Country / region: United States Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20031
20051
20061
20072
20081
20103
20111
20123
20132
20143
20151
20162
20172
20187
20193
20205
20224
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed65

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)21
Bristol-Myers Squibb6
Cytokinetics4
Mayo Clinic3
MyoKardia, Inc.3
The Cleveland Clinic3
Brigham and Women's Hospital2
Massachusetts General Hospital2
University of Texas Southwestern Medical Center2
Wayne State University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Hypertrophic65
Cardiomegaly5
Cardiomyopathy, Dilated5
Heart Diseases5
Hypertrophy, Left Ventricular5
Arrhythmias, Cardiac4
Cardiovascular Diseases4
Coronary Artery Disease4
Cardiomyopathies3
Coronary Disease3

Trials

Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.